Who is sponsoring NCT04144465?

NCT04144465 is sponsored by Suez Canal University.

What drugs are being tested in NCT04144465?

Interventions in NCT04144465: NORADRENALIN, PHENYLEPHRINE.

What condition does NCT04144465 study?

NCT04144465 studies Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Is NCT04144465 still recruiting?

NCT04144465 is currently completed. Last updated 29 May 2024.

Last reviewed 2024-05-29 · How we verify

NCT04144465

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Noradrenaline Infusion Versus Phenylephrine Infusion in Improving Serum Lactate Level in HIPEC

Completed NA Last updated 29 May 2024

What this trial tests

NA trial testing NORADRENALIN in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in 30 participants. Completed in 30 December 2023.

Timeline

1 November 2019

Primary endpoint
30 October 2023

30 December 2023

Quick facts

Lead sponsor	Suez Canal University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	30
Start date	1 November 2019
Primary completion	30 October 2023
Estimated completion	30 December 2023
Sites	1 location across Egypt

Drugs / interventions tested

NORADRENALIN — full drug profile →
PHENYLEPHRINE (phenylephrine) — full drug profile →

Conditions studied

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) — all drugs for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) →

Sponsor

Suez Canal University

Who can join

35 and older, any sex, with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

ABG PARAMETERS ARE CHANGED DURING HIPEC, WE TRIED TO FIND COMPARISON BETWEEN NORADRENALINE AND PHENYLEPHRINE IN OPTIMIZING ABG PARAMETERS THAT REFLECTS ORGAN PERFUSIONS ESPECIALLY SERUM LACTATE

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Suez Canal University trials

Trials by the same sponsor.

NCT07263893 — Inter Flex Three Dimensional Plate in Management of Mandibular Fracture RCT · NA · recruiting
NCT07280533 — Accuracy of Virtual Surgical Planning Versus Traditional Technique in Zygomaticomaxillary Fracture Reduction · NA · not yet recruiting
NCT07291791 — tDCS for Pain Modulation in Knee Osteoarthritis · NA · active not recruiting
NCT07262086 — Clinical Evaluation of Wear Resistance and Bioactivity of Self Cured Bioactive Resin Composite · NA · enrolling by invitation
NCT07125846 — Efficacy of Bioactive Glass vs. Xenograft in Maxillary Sinus Augmentation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04144465 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Suez Canal University
Last refreshed: 29 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04144465.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing